G1 Therapeutics Aktie
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
G1 Therapeutics Aktie Analyse
| 07.02.19 | G1 Therapeutics Buy | B. Riley FBR | |
| 08.11.18 | G1 Therapeutics Buy | Needham & Company, LLC | |
| 10.09.18 | G1 Therapeutics Buy | BTIG Research | |
| 29.05.18 | G1 Therapeutics Buy | H.C. Wainwright & Co. | |
| 18.05.18 | G1 Therapeutics Buy | Needham & Company, LLC | |
| 12.06.17 | G1 Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
| 12.06.17 | G1 Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung